AptarGroup is executing a strategic pivot toward higher-margin pharma delivery systems, evidenced by double-digit consumer healthcare growth and a 6.3% revenue acceleration in 2026Q2. However, the company's gross margin has contracted 300 basis points year-ove...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue grew 6.3% year-over-year to $1.0B in 2026Q2, but gross margin fell 300 basis points to 27.8% and net margin dropped to 8.5% from 11.6%, reflecting mix shift and elevated R&D.
The bull case argues for a premium EBITDA multiple (16x-20x) due to superior growth, high margins, and a recurring revenue model, typical of leading med-tech and life sciences companies.
AptarGroup declared a quarterly cash dividend, demonstrating financial stability and commitment to returning capital to shareholders.
Advancements in nasal vaccine and eye care delivery, including collaborations with CastleVax and Bausch and Lomb, position AptarGroup as a leader in medical device innovation.
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 30, 2026 | $1.42+5.2% vs $1.35 | $1.0B+1.7% vs $1.0B |
Q2 2026 Apr 30, 2026 | $1.19+3.5% vs $1.15 | $983M+2.8% vs $956M |
Q1 2026 Feb 5, 2026 | $1.25+0.8% vs $1.24 | $963M+9.6% vs $879M |
Q4 2025 Oct 30, 2025 | $1.62+3.2% vs $1.57 | $961M+9.2% vs $880M |
Tidal Investments LLC lowered its position in AptarGroup, Inc. (NYSE: ATR) by 24.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,987 shares of the industrial products company's stock after selling 5,814 shares during the quarter. Tidal Investments LLC's holdings
VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in AptarGroup, Inc. (NYSE: ATR) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 4,200 shares of the industrial products company's stock, valued at approximately $526,000. Other institutional investors have also recently bought and
AptarGroup, Inc. (ATR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
AptarGroup, Inc. (ATR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Benchmark ATR against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for AptarGroup, Inc. (ATR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $124.74 | $7.96B | 21.21 | 5.42% | 10.4% | 15.11% | 1.45% | |
| $37.15 | $3.93B | 13.76 | 10.73% | 4.05% | 11.69% | — | |
| $42.15 | $6.21B | 12.29 | -0.61% | 9.43% | 48.39% | — | |
| $50.63 | $5.01B | 12.72 | 41.72% | 8.67% | 18.3% | — | |
| $42.80 | $19.79B | 17.98 | 56.61% | 4.71% | 9.44% | — | |
| $240.98 | $21.47B | 28.09 | 7.23% | 7.25% | 14.86% | — |
AptarGroup, Inc. (ATR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
AptarGroup, Inc. (ATR) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 30, 2026·SEC
May 13, 2026·SEC
May 7, 2026·SEC
Get notified when ATR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AptarGroup, Inc. (ATR) stock FAQ — growth, dividends, profitability & financials explained
AptarGroup, Inc. (ATR) reported $3.93B in revenue for fiscal year 2025. This represents a 539% increase from $615.8M in 1996.
AptarGroup, Inc. (ATR) grew revenue by 5.4% over the past year. This is steady growth.
Yes, AptarGroup, Inc. (ATR) is profitable, generating $362.5M in net income for fiscal year 2025 (10.4% net margin).
Yes, AptarGroup, Inc. (ATR) pays a dividend with a yield of 1.45%. This makes it attractive for income-focused investors.
AptarGroup, Inc. (ATR) has a return on equity (ROE) of 15.1%. This is reasonable for most industries.
AptarGroup, Inc. (ATR) generated $310.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
